Cargando…

Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer

PURPOSE: Hormone receptor (HR)-positive, Human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) requires a therapeutic approach that takes into account multiple factors, with treatment being based on anti-estrogen hormone therapy (HT). As consensus documents are valu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alvarez-Lopez, I., Bezares, S., Dalmau Portulas, E., García-Martínez, E., García-Sáenz, J. Á., Gil-Gil, M., Martínez de Dueñas, E., Ribelles, N., Santaballa Bertrán, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316841/ https://www.ncbi.nlm.nih.gov/pubmed/32052382 http://dx.doi.org/10.1007/s12094-019-02269-7

Ejemplares similares

Luminal B breast tumors are not HER2 positive
por: Bhargava, Rohit, et al.
Publicado: (2008)

HER2 status and disparities in luminal breast cancers
por: Holowatyj, Andreana N., et al.
Publicado: (2016)

THE TOTAL LUMINOUS EFFICIENCY OF LUMINOUS BACTERIA
por: Harvey, E. Newton
Publicado: (1925)

Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers
por: Hashmi, Atif Ali, et al.
Publicado: (2018)

Multiple-criteria decision making: concepts, techniques, and extensions
por: Yu, Po-Lung
Publicado: (1985)

Shared decision making: relevant concepts and facilitating strategies
por: Bae, Jong-Myon
Publicado: (2017)

Palbociclib Rechallenge for Hormone Receptor–Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial
por: Albanell, Joan, et al.
Publicado: (2023)

Luminal B breast tumors are not HER2 positive – authors' response
por: Tamimi, Rulla M, et al.
Publicado: (2008)

Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumors with different genotype
por: Yanagawa, Masumi, et al.
Publicado: (2012)

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes
por: Maisonneuve, Patrick, et al.
Publicado: (2014)

Differences in clinical outcomes between HER2-negative and HER2-positive luminal B breast cancer
por: Kang, Byeongju, et al.
Publicado: (2023)

Survival analysis of bevacizumab plus taxane treatment in luminal metastatic breast cancer
por: Murillo, Serafin Morales, et al.
Publicado: (2021)

An ABC for decision making
por: Garcia, Luiz Henrique Costa, et al.
Publicado: (2015)

Causal correlation paths across cortical areas in decision making
por: Campo, Adrià Tauste, et al.
Publicado: (2014)

Conceptions of decision-making capacity in psychiatry: interviews with Swedish psychiatrists
por: Sjöstrand, Manne, et al.
Publicado: (2015)

EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2(+), basal-like, and HER2 intrinsic subtypes of breast cancer
por: Soysal, S D, et al.
Publicado: (2013)

Orthopedic Surgeons’ Perspectives on the Decision-Making Process for the Use of Bioprinter Cartilage Grafts: Web-Based Survey
por: Salvador Verges, Àngels, et al.
Publicado: (2019)

A Proof-of-Concept Ecological Momentary Assessment Study of Day-Level Dynamics in Value-Based Decision-Making in Opioid Addiction
por: Alvarez, Emmanuel E., et al.
Publicado: (2022)

Spontaneous Epithelial-Mesenchymal Transition and Resistance to HER-2-Targeted Therapies in HER-2-Positive Luminal Breast Cancer
por: Lesniak, David, et al.
Publicado: (2013)

CCNE1 and PLK1 Mediate Resistance to Palbociclib in HR+/HER2− Metastatic Breast Cancer
por: Guerrero-Zotano, Ángel, et al.
Publicado: (2023)

Quantum stochastic walks on networks for decision-making
por: Martínez-Martínez, Ismael, et al.
Publicado: (2016)

Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy
por: Manso, L, et al.
Publicado: (2011)

The Making of Leukemia
por: González-Herrero, Inés, et al.
Publicado: (2018)

Real-world treatment in patients with HER2+ metastatic breast cancer: Treatment decisions in HER2+ mBC
por: Colomer, R., et al.
Publicado: (2017)

Shared decision-making in Israel: status, barriers, and recommendations
por: Miron-Shatz, Talya, et al.
Publicado: (2012)

The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer
por: Akhoundova, D., et al.
Publicado: (2020)

“I Want Her to Make Correct Decisions on Her Own:” Former Soviet Union Mothers' Beliefs about Autonomy Development
por: Komolova, Masha, et al.
Publicado: (2018)

The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer
por: Orea-Soufi, Alba, et al.
Publicado: (2021)

Intrinsic subtypes and therapeutic decision-making in hormone receptor-positive/HER2-negative metastatic breast cancer with visceral crisis: A case report
por: Schettini, Francesco, et al.
Publicado: (2022)

Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
por: Pascual, Javier, et al.
Publicado: (2023)

Adult Spinal Deformity: Current Concepts and Decision-Making Strategies for Management
por: Kim, Hong Jin, et al.
Publicado: (2020)

A Concept Analysis of Nurses’ Clinical Decision Making: Implications for Korea
por: Oh, Sunyoung, et al.
Publicado: (2022)

High Mutation Burden in ER-Positive/HER2-Negative/Luminal Breast Cancers
por: Voutsadakis, Ioannis A.
Publicado: (2022)

Comparison of endocrine therapy and chemotherapy as different systemic treatment modes for metastatic luminal HER2-negative breast cancer patients —A retrospective study
por: Liu, Qiuyue, et al.
Publicado: (2022)

Patients’ and Caregivers’ Conceptualisations of Pressure Ulcers and the Process of Decision-Making in the Context of Home Care
por: García-Sánchez, Francisco José, et al.
Publicado: (2019)

How priming with body odors affects decision speeds in consumer behavior
por: Alcañiz, Mariano, et al.
Publicado: (2023)

Psychosocial aspects and life project disruption in young women diagnosed with metastatic hormone-sensitive HER2-negative breast cancer
por: Vila, Mireia Margelí, et al.
Publicado: (2020)

Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2− Metastatic Breast Cancer: A Podcast
por: Dong, Brian, et al.
Publicado: (2023)

Combined quantitative measures of ER, PR, HER2, and KI67 provide more prognostic information than categorical combinations in luminal breast cancer
por: Abubakar, Mustapha, et al.
Publicado: (2019)

Deciphering HER2 Breast Cancer Disease: Biological and Clinical Implications
por: Godoy-Ortiz, Ana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hl4880ifcpusbliuu9ulc0v6e6